APA (7th ed.) Citation

D, B., C, P., H, L., G, A., P, P., D, S., . . . AM, D. (2004). Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: A phase II study of the Hellenic Cooperative Oncology Group. British journal of cancer, 91(9), 1639. https://doi.org/10.1038/sj.bjc.6602148

Chicago Style (17th ed.) Citation

D, Bafaloukos, et al. "Combination of Pegylated Liposomal Doxorubicin (PLD) and Paclitaxel in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of the Hellenic Cooperative Oncology Group." British Journal of Cancer 91, no. 9 (2004): 1639. https://doi.org/10.1038/sj.bjc.6602148.

MLA (9th ed.) Citation

D, Bafaloukos, et al. "Combination of Pegylated Liposomal Doxorubicin (PLD) and Paclitaxel in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of the Hellenic Cooperative Oncology Group." British Journal of Cancer, vol. 91, no. 9, 2004, p. 1639, https://doi.org/10.1038/sj.bjc.6602148.